RxSight, Inc. (RXST)
RXST moved a median of -0.21% 30 minutes after news, and -0.20% by the close. How RXST actually reacts to news — the realized, point-in-time move the market made, measured across 1,302 labeled events over the last three years with zero look-ahead.
RXST’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.15% | 37% | 1,288 |
| 30-min | -0.21% | 39% | 1,294 |
| 60-min | -0.12% | 46% | 1,294 |
| to close | -0.20% | 48% | 1,257 |
| Middle 50% of RXST reactions | -1.28% to +0.55% |
|---|---|
| Median reaction (30-min) | -0.21% |
| Measured reactions | 1,302 |
Half of all RxSight, Inc. news events land between -1.28% and +0.55% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How RXST reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 11 | +0.94% | 73% | +3.02% |
| Analyst downgrades | 29 | +0.14% | 52% | +3.97% |
| Coverage initiations | 19 | +0.78% | 58% | +4.88% |
| Rating reiterations | 74 | +0.10% | 53% | +1.31% |
| Price-target raises | 21 | -0.10% | 48% | -0.98% |
| Price-target cuts | 26 | +0.12% | 54% | +2.37% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how RXST ranks against every other measured name →
That’s how RXST usually reacts — get an email when it moves on news →Email me when RXST moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to RXST's baseline. Nothing else.
Recent RXST events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3 | Press release | GlobeNewswire | — | — | |
| RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation | Press release | GlobeNewswire | +1.46% | +5.39% | |
| RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference | Press release | GlobeNewswire | +1.73% | +3.93% | |
| Form 10-Q RxSight, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +1.33% | |
| Form 8-K RxSight, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.33% | |
| RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook | Press release | GlobeNewswire | +0.00% | +1.33% | |
| RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules | Press release | GlobeNewswire | +0.95% | +7.43% | |
| Form S-8 RxSight, Inc. | SEC filing · Form S-8 | SEC EDGAR | -1.11% | -3.89% | |
| Form 8-K RxSight, Inc. For: Jul 13 | SEC filing · Form 8-K | SEC EDGAR | +8.50% | +10.08% | |
| RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer | Press release | GlobeNewswire | +8.50% | +10.08% | |
| Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs | Press release | GlobeNewswire | -0.53% | +2.18% | |
| Form 8-K RxSight, Inc. For: Jul 06 | SEC filing · Form 8-K | SEC EDGAR | -0.53% | +2.18% | |
| Form 8-K RxSight, Inc. For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | -0.53% | +2.18% | |
| RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement | Press release | GlobeNewswire | -0.53% | +2.18% | |
| Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -0.18% | +1.35% | |
| Form 8-K RxSight, Inc. For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | -0.95% | -2.55% | |
| Form SD RxSight, Inc. | SEC filing · Form SD | SEC EDGAR | -0.76% | -1.13% | |
| RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum | Press release | GlobeNewswire | -1.77% | +3.88% | |
| Form 10-Q RxSight, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.82% | -6.60% | |
| Form 8-K RxSight, Inc. For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +2.82% | -6.60% | |
| RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook | Press release | GlobeNewswire | +2.82% | -6.60% | |
| RxSight, Inc. to Present at the Bank of America Healthcare Conference | Press release | GlobeNewswire | +0.22% | +3.67% | |
| Form ARS RxSight, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -1.55% | -4.08% | |
| Form DEF 14A RxSight, Inc. For: Apr 27 | SEC filing · Form DEF | SEC EDGAR | -1.55% | -4.08% | |
| Form DEFA14A RxSight, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -1.55% | -4.08% | |
| RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 | Press release | GlobeNewswire | -0.75% | -1.91% | |
| RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 | Press release | GlobeNewswire | +0.00% | -5.58% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | — | +0.00% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | -1.27% | +5.09% | |
| RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference | Press release | GlobeNewswire | -1.27% | +5.09% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.85% | +4.23% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.30% | -1.81% | |
| RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.15% | -3.04% | |
| Form 8-K/A RxSight, Inc. For: Jan 11 | SEC filing · Form 8-K | SEC EDGAR | -0.89% | -5.01% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.07% | +2.58% | |
| RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.47% | +0.40% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.13% | +0.93% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.07% | -2.28% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.51% | -0.64% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +1.66% | +4.97% | |
| Form EFFECT RxSight, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -0.89% | -4.59% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -2.50% | -1.00% | |
| Form 10-K RxSight, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +8.02% | +4.07% | |
| Form 8-K RxSight, Inc. For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | +8.02% | +4.07% | |
| Form POS AM RxSight, Inc. | SEC filing · Form POS | SEC EDGAR | +8.02% | +4.07% | |
| Form S-8 RxSight, Inc. | SEC filing · Form S-8 | SEC EDGAR | +8.02% | +4.07% | |
| RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance | Press release | GlobeNewswire | +8.02% | +4.07% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | +2.19% | |
| RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.56% | +1.74% | |
| Form POSASR RxSight, Inc. | SEC filing · Form POSASR | SEC EDGAR | +2.84% | +6.43% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the RXST section they belong to.
Where else RXST is measured.
RXST earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is RxSight, Inc.'s median reaction calculated?
Every labeled RXST news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,302 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of RXST's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does RXST's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.